Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
ConclusionUninterrupted edoxaban therapy represents an alternative to uninterrupted VKA treatment in patients undergoing AF ablation.
Source: European Heart Journal - Category: Cardiology Source Type: research
More News: Atrial Fibrillation | Bleeding | Brain | Cardiology | Heart | Hemorrhagic Stroke | Ischemic Stroke | MRI Scan | Neurology | Stroke | Study | Thrombosis | Vitamin K | Vitamins